Restart Life Sciences Announces Private Placement Financing

Core Viewpoint - Restart Life Sciences Corp. is initiating a non-brokered private placement to raise up to CAD $1,000,000 through the sale of 10,000,000 units at CAD $0.10 each, aimed at advancing its initiatives in brain health and wellness [1][3]. Group 1: Offering Details - The private placement will consist of units, each including one common share and one transferable common share purchase warrant, allowing the holder to purchase an additional common share at CAD $0.10 for one year [2]. - The total gross proceeds from the offering are expected to be up to CAD $1,000,000 [1]. Group 2: Use of Proceeds - The funds raised will be allocated towards health food trials, potential acquisitions, and general working capital [4]. - The company is focused on progressing its initiatives in brain health and overall wellness, which will be supported by this financing [3]. Group 3: Company Overview - Restart Life Sciences Corp. is a Canadian-based life sciences company listed on the Canadian Securities Exchange [5].